This is a test
- 180 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Risk Management in Blood Transfusion Medicine
Book details
Book preview
Table of contents
Citations
About This Book
Get a quick, expert overview of risk management in transfusion medicine from Dr. James Mills Barbeau. This practical resource presents a summary of today's state-of-the-art techniques for reducing harm during all phases of transfusion practice, including blood collection, testing, processing, clinical assessment, and transfusion. It's an easy-to-read, one-stop resource for managing and mitigating the various levels of risk in a variety of transfusion settings and scenarios.
- Presents a well-rounded perspective on quality assurance, blood supply testing, clinical risk, ethical and legal considerations, and transfusion-transmitted infectious diseases.
- Demonstrates how transfusion risk-management programs add value to health care institutions by enhancing a culture of safety, improving the institution's reputation, and improving the bottom line.
- Consolidates today's available information on risk management in blood transfusion medicine into one convenient resource.
Frequently asked questions
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlegoâs features. The only differences are the price and subscription period: With the annual plan youâll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Risk Management in Blood Transfusion Medicine by J. Mills Barbeau in PDF and/or ePUB format, as well as other popular books in Medicine & Hematology. We have over one million books available in our catalogue for you to explore.
Information
Topic
MedicineSubtopic
HematologyChapter 1
Enterprise Risk ManagementâWhat It Is and Why It Matters
J. Mills Barbeau, MD, JD
Abstract
At the institutional level, risk can be defined as any factor that can jeopardize an organizationâs ability to achieve its business objectives. This chapter presents enterprise risk management (ERM), a crucial business method for identifying risks throughout an organization and harmonizing risk- management efforts enterprise-wide. Healthcare organizations with effective risk management strategies have a competitive advantage over those that fail to manage their risk portfolio adequately. The present chapter reviews the history leading to ERMâs ascent to the standard of care for all major enterprises, including healthcare organizations, and describes how to implement ERM at oneâs institution.
Keywords
Enterprise risk management; Internal controls; Risk; Risk audit; Risk domains; Sarbanes-Oxley
Introduction
âRiskâ can mean many things. Risk connotes an absence of safety, and the possibility of suffering a loss. In healthcare, patient safety efforts concentrate on risks such as the risk of falling or the performance of âriskyâ procedures. We use timeouts to minimize the risk of wrong-side surgery. Risk is associated with potential financial loss, legal liability, or both. Yet, we also talk about risk being related to opportunity, as when we decide that something is âworth the risk.â In decision making, we frequently âweigh the risks,â including the risk of doing nothing, before choosing a course of action. The corporate world defines risk as any factor that can jeopardize the organizationâs ability to achieve its business objectives.1 Could this definition of risk apply to healthcare organizations?
What, then, is risk management? In practice, risk management typically involves identifying risks and minimizing themâby eliminating the risks, implementing procedures to reduce the risks, educating personnel on how to avoid the risks, or buying insurance to outsource the financial impact of the risks. Risk management is typically performed within a given serviceâs span of responsibility, at the level of a department, unit, or division. A threshold issue is whether such a balkanized approach to risk management is maximally effective, or whether it might be preferable to address risks at the organizational level, taking advantage of economies of scale. One may counter that a local approach to risk management effectively brings risks to the attention of those with the most expertise and experience regarding risks in their spheres of activity. In addition, human nature being what it is, managing risk across departmental domains may give rise to feelings that one group is criticizing another or otherwise overstepping its bounds.
The term âenterprise risk managementâ (ERM) may not be familiar to most healthcare professionals. This is largely because enterprise risk management did not originate in healthcare, but rather in the corporate world. Although ERM may not have become part of healthcare culture or consciousness at the provider level, the impact of ERM is nevertheless felt at all levels of any large healthcare organization. To appreciate why enterprise risk management is important, it is helpful to understand some interesting historic background.
Sarbanes-Oxley Act of 2002
Some readers may recall the Enron and WorldCom corporate fraud scandals of 2001. Both Enron and WorldCom were successful, respected companies that had thrived throughout the 1990s. Enron was a large energy company, named âAmericaâs Most Innovative Companyâ by Fortune Magazine for six consecutive years up to 2001.2 In 1999, Enron started an electronic commodities-trading website, and soon thereafter, it invested heavily in high-speed broadband networks. Unfortunately for Enronâs employees and investors, the âdot comâ bubble burst, and the arrival of economic recession in 2000 led to multibillion dollar losses for many web-based companies.3 In an attempt to hide its losses, Enronâs executivesâwith the support of its accounting firm, Arthur Andersonâengaged in fraudulent accounting practices.4,5 By the time the fraud was discovered, shareholders and employee pensions had lost billions of dollars. Enron and Arthur Anderson collapsed and Enronâs CEO, Jeffrey Skilling, was convicted of fraud, insider trading, and conspiracy.
WorldCom was also a progressive telecommunications company that prospered during the 1990s. In 1997, WorldCom announced a merger with MCI Communications Corporation, which would be the largest corporate merger in the US history. Two years later, WorldCom announced a merger with Sprint. The proposed new company would be larger than AT&T. However, the Justice Department balked at the Sprint-WorldCom merger on anticompetitive grounds and the merger failed. By then, the telecommunications industry was in decline. When the merger failed, WorldCom share prices dropped precipitously. The company was no longer the darling of investors. Financial weakness in WorldComâs organization began to become apparent. Similar to the CEO at Enron, WorldComâs CEO, Bernard Ebbers, began to doctor the books with the assistance of the same accounting firm, Arthur Anderson.6,7 Whistle blowers within the company sounded an alert,8 and WorldCom plunged into a downward spiral. The company filed for bankruptcy in 2002.9 Similar to Skilling, Ebbersâ career ended in federal prison.10
In the wake of the Enron/WorldCom scandals and Arthur Andersonâs collapse, Congress passed the Sarbanes-Oxley Act of 2002.11 It had become clear that many corporations made a practice of hiring a single accounting firm to act as both external auditors and internal consultants, as was the case with Arthur Anderson. As external, âindependentâ auditors, the accountants would perform the corporationâs annual external audit on behalf of investors and shareholders. During the rest of the year the same accountants were paid handsomely by the corporation to act as consultants. Thus, the accountants were in essence working for the corporation, and the external audits were a sham. Sarbanes-Oxley mandates that external auditors of publically traded corporations shall not have such conflicts of interest. Furthermore, CEOs are personally responsible for the accuracy of the companyâs financial reports. The CEO and senior executives must all personally verify the companyâs internal controls. âInternal controlsâ is an auditing term for risk management.12
The mandate to implement comprehensive internal controls (i.e., risk management practices) requires company leadership and the external auditor to perform a âtop-down risk assessmentâ of the entire organization.13,14 Specifically, the company must identify all factors that could jeopardize the companyâs ability to achieve its business objectives. Leadership must establish a âsystems cultureâ in which control consciousness permeates the entire organization and systems are in place to identify and share information about risk. Comprehensive control activities, embodied in clear policies and procedures, must harmonize risk management across the enterprise, and the risk management process must be continuously monitored and improved.
The Sarbanes-Oxley Act has had a far-reaching impact, which extends into the realm of healthcare. Although compliance is mandatory only for publically traded corporations, the enterprise risk management paradigm has become the standard for all significant business enterprises. This makes good business sense. Not only do such practices protect against losses, but a comprehensive, fully integrated risk management program also favorably impacts a companyâs credit rating. After all, a company that has effectively minimized its risks is a less âriskyâ investment for shareholders and lenders. Healthcare organizations, similar to other large companies, avail themselves of bonds, loans, and capital markets. A good credit rating improves access to capital, which in turn enables organizations to seize business opportunities when they arise. Effective risk management can be a competitive advantage in competitive markets, healthcare15 or otherwise.16
Enterprise risk management also allows the company to weather disruptive events. Market volatility and uncertainty, economic shocks, and new competition or technology can rapidly upset the competitive terrain (Fig. 1.1). An organization that has thoroughly ...
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of Contributors
- Preface
- Chapter 1. Enterprise Risk ManagementâWhat It Is and Why It Matters
- Chapter 2. Quality Systems in Transfusion Medicine
- Chapter 3. Regulatory Oversight of Transfusion Medicine
- Chapter 4. Procedures for Protection
- Chapter 5. Transfusion-Transmitted Infectious Diseases
- Chapter 6. Transfusion Review: Monitoring Transfusion Practice
- Chapter 7. Patient Blood Management: Reducing Risk by Reducing Inappropriate and Avoidable Transfusions
- Chapter 8. Transfusion Risk Management in Children and Neonates
- Chapter 9. Informed Consent
- Chapter 10. Transfusion Medicine and the Law
- Chapter 11. Treating Jehovahâs Witness Patients
- Chapter 12. Risk Management in Massive Transfusion
- Chapter 13. Clinical Risk in Apheresis-Derived Cellular Therapy
- Chapter 14. Research Risks in Transfusion Medicine and Cellular Therapy
- Chapter 15. Risk-Based Decision Making in Transfusion Medicine
- Index